<VariationArchive VariationID="2203121" VariationName="NM_001298.3(CNGA3):c.1443dup (p.Ile482fs)" VariationType="Duplication" Accession="VCV002203121" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2023-02-08" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1925349" VariationID="2203121">
      <GeneList>
        <Gene Symbol="CNGA3" FullName="cyclic nucleotide gated channel subunit alpha 3" GeneID="1261" HGNC_ID="HGNC:2150" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="98346456" stop="98398601" display_start="98346456" display_stop="98398601" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="98962617" stop="99015063" display_start="98962617" display_stop="99015063" Strand="+" />
          </Location>
          <OMIM>600053</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001298.3(CNGA3):c.1443dup (p.Ile482fs)</Name>
      <CanonicalSPDI>NC_000002.12:98396612:C:CC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="98396612" stop="98396613" display_start="98396612" display_stop="98396613" variantLength="1" positionVCF="98396612" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="99013075" stop="99013076" display_start="99013075" display_stop="99013076" variantLength="1" positionVCF="99013075" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>I464fs</ProteinChange>
      <ProteinChange>I482fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.99013076dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.99013076dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.98396613dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.98396613dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009097.1" sequenceAccession="NG_009097" sequenceVersion="1" change="g.55459dup">
            <Expression>NG_009097.1:g.55459dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001079878.2" sequenceAccession="NM_001079878" sequenceVersion="2" change="c.1389dup">
            <Expression>NM_001079878.2:c.1389dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001073347.1" sequenceAccession="NP_001073347" sequenceVersion="1" change="p.Ile464fs">
            <Expression>NP_001073347.1:p.Ile464fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001298.3" sequenceAccession="NM_001298" sequenceVersion="3" change="c.1443dup" MANESelect="true">
            <Expression>NM_001298.3:c.1443dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001289.1" sequenceAccession="NP_001289" sequenceVersion="1" change="p.Ile482fs">
            <Expression>NP_001289.1:p.Ile482fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001298.3(CNGA3):c.1443dup (p.Ile482fs) AND Achromatopsia 2" Accession="RCV003329464" Version="2">
        <ClassifiedConditionList TraitSetID="6436">
          <ClassifiedCondition DB="MedGen" ID="C1857618">Achromatopsia 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001298.3(CNGA3):c.1443dup (p.Ile482fs) AND not provided" Accession="RCV002664249" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-27" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-02-08" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14757870</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28159970</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32913385</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6436" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="171" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Achromatopsia 2</ElementValue>
                <XRef ID="Achromatopsia+2/116" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009003" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Colorblindness, total</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rod monochromatism 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rod monochromacy 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ACHM2</ElementValue>
                <XRef Type="MIM" ID="216900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RMCH2</ElementValue>
                <XRef Type="MIM" ID="216900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CNGA3</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9649" />
                <XRef ID="9649" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Achromatopsia is characterized by reduced visual acuity, pendular nystagmus, increased sensitivity to light (photophobia), a small central scotoma, eccentric fixation, and reduced or complete loss of color discrimination. All individuals with achromatopsia (achromats) have impaired color discrimination along all three axes of color vision corresponding to the three cone classes: the protan or long-wavelength-sensitive cone axis (red), the deutan or middle-wavelength-sensitive cone axis (green), and the tritan or short-wavelength-sensitive cone axis (blue). Most individuals have complete achromatopsia, with total lack of function of all three types of cones. Rarely, individuals have incomplete achromatopsia, in which one or more cone types may be partially functioning. The manifestations are similar to those of individuals with complete achromatopsia, but generally less severe. Hyperopia is common in achromatopsia. Nystagmus develops during the first few weeks after birth followed by increased sensitivity to bright light. Best visual acuity varies with severity of the disease; it is 20/200 or less in complete achromatopsia and may be as high as 20/80 in incomplete achromatopsia. Visual acuity is usually stable over time; both nystagmus and sensitivity to bright light may improve slightly. Although the fundus is usually normal, macular changes (which may show early signs of progression) and vessel narrowing may be present in some affected individuals. Defects in the macula are visible on optical coherence tomography.</Attribute>
                <XRef ID="NBK1418" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301591</ID>
                <ID Source="BookShelf">NBK1418</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="pmc">3110037</ID>
              </Citation>
              <XRef ID="49382" DB="Orphanet" />
              <XRef ID="C1857618" DB="MedGen" />
              <XRef ID="MONDO:0009003" DB="MONDO" />
              <XRef Type="MIM" ID="216900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7553764" SubmissionDate="2023-09-27" DateLastUpdated="2023-09-30" DateCreated="2023-09-30">
        <ClinVarSubmissionID localKey="variant:8344193" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV004036169" DateUpdated="2023-09-30" DateCreated="2023-09-30" Type="SCV" Version="1" SubmitterName="Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen" OrgID="506385" OrganizationCategory="laboratory" OrgAbbreviation="IMGAG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Disease">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0011516" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CNGA3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="2" alternateAllele="GC" referenceAllele="G" start="98396612" stop="98396612" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">238876374</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="216900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13866737</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6213890" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4831877|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003524940" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32913385</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14757870</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28159970</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the CNGA3 protein in which other variant(s) (p.Arg661His) have been determined to be pathogenic (PMID: 32913385; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This premature translational stop signal has been observed in individuals with achromatopsia (PMID: 14757870, 28159970). This variant is present in population databases (rs778373042, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Ile482Hisfs*6) in the CNGA3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 213 amino acid(s) of the CNGA3 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CNGA3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.99013075_99013076insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6213890" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7553764" TraitType="Disease" MappingType="XRef" MappingValue="216900" MappingRef="OMIM">
        <MedGen CUI="C1857618" Name="Achromatopsia 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7553764" TraitType="Disease" MappingType="XRef" MappingValue="HP:0011516" MappingRef="HP">
        <MedGen CUI="C0152200" Name="Achromatopsia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

